Stocktoria
Pyxis Oncology, Inc. PYXS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-08
Pyxis Oncology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,785,895 | $9.2M | 4.44% |
| RENAISSANCE TECHNOLOGIES LLC | 772,232 | $2.3M | 1.23% |
| MILLENNIUM MANAGEMENT LLC | 233,004 | $701,342 | 0.37% |
| TWO SIGMA INVESTMENTS, LP | 83,961 | $252,723 | 0.13% |
| CITADEL ADVISORS LLC | 62,017 | $186,671 | 0.1% |
| Point72 Asset Management, L.P. | 37,092 | $111,647 | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.